ALK | Allergy solutions for life
ALK

Pioneering in the field of respiratory allergies for more than a century, we've embarked on a mission to help more people, with more solutions, more efficiently.

News

  • Post date
    05/02/2025
    ALK enters into neffy® co-promotion agreement in the USA
  • Post date
    04/29/2025
    Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
  • Post date
    04/23/2025
    ITULAZAX® tree pollen tablet approved for treatment of children in Europe
Apply for the Henning Løwenstein Research Award 2025
The prestigious Henning Løwenstein Research Award is given to a young scientist who has shown excellence within the field of allergy. Don't miss the opportunity to apply. The deadline is 15 August 2025.
Image
ALK homepage video thumbnail
We are the pioneers of allergy solutions

For more than a 100 years, ALK has been at the forefront of allergy research and treatment. We're on a mission to help even more people globally, reaching 5 million people a year by 2030.

ALK in brief

Avatar

Allergy solutions

Allergy is caused by an overreaction of the body’s immune system to substances that in most cases would otherwise be harmless. Learn about the chronic disease, diagnosis, and treatment options.

Avatar

Sustainability

We aim to operate in a sustainable and ethical manner across our business and we underpin these aims with a range of policies and commitments.

Avatar

Careers

Become part of a team that is passionate about making a difference for people living with allergy. In our global company, we share expertise and knowledge across boarders and cultures and have a focus on continuous employee development.